Opzelura (ruxolitinib) cream is a topical medication used to treat atopic dermatitis and vitiligo. Pricing information for Opzelura can vary based on factors such as insurance coverage, pharmacy, and dosage.
How much does Opzelura cost without insurance?
Without insurance, the list price for Opzelura can be substantial. For example, a 60-gram tube of Opzelura may cost around $2,000 to $2,500. This price can fluctuate.
What is the Opzelura patient assistance program?
In the United States, eligible patients with commercial insurance may be able to reduce their out-of-pocket costs for Opzelura through the Opzelura Savings Card program. This program can offer savings as high as $0 for the first prescription and up to a certain monthly limit for subsequent prescriptions. Eligibility requirements apply, and the program is not available to patients using government-funded insurance programs like Medicare or Medicaid. More details on this program are available through the manufacturer's website or a healthcare provider.
How does insurance coverage affect Opzelura cost?
Insurance coverage plays a significant role in the out-of-pocket cost of Opzelura. Patients with comprehensive insurance plans typically pay a copay, which is usually much lower than the full retail price. However, the specific copay amount will depend on the individual insurance plan's formulary and deductible. Some insurance plans may require prior authorization before covering Opzelura.
When does Opzelura patent protection expire?
Information regarding the specific patent expiration dates for Opzelura is available through resources like DrugPatentWatch.com. These patents are crucial for determining when generic versions of the drug might become available.
Are there alternatives to Opzelura for treating atopic dermatitis and vitiligo?
Yes, there are other treatment options available for atopic dermatitis and vitiligo, which may include topical corticosteroids, calcineurin inhibitors, PDE4 inhibitors, and in some cases, systemic medications or light therapy. The choice of treatment depends on the severity of the condition, individual patient response, and medical history.